Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. (Q27853215)
Jump to navigation
Jump to search
scientific article
- Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. |
scientific article |
|
Statements
1 reference
Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. (English)
1 reference
Giovanna Forte
Antonio Matrone
Aldo Germani
Monica Rutigliano
Rosanna Bagnulo
Daria Loconte
Vanessa Galleggiante
Simona Cagiano
Pantaleo Bufo
Senia Trabucco
2 November 2015
0 references
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references